Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ico Therapeutics Inc (ICO.VN)

Ico Therapeutics Inc (ICO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ico Therapeutics Inc 777 Hornby Street 6th Floor Vancouver BC V6Z 1S4 CAN

www.icotherapeutics.com P: 604-657-3882

Sector:

Medical

INDUSTRY GROUPING:

TSX Biotechnology

Description:

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. Geographically, it operates in Canada and Australia.

Key Statistics

Overview:

Market Capitalization, $K 19,036
Shares Outstanding, K 9,065
% of Institutional Shareholders 6.45%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -1,488 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -772 K

Growth:

1-Year Return 250.00%
3-Year Return 200.00%
5-Year Return 133.33%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%

Per-Share Information:

Next Earnings Date 08/30/21
Earnings Per Share ttm -0.21
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -9.76%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 08/18/21

ICO.VN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,037.01%
Return-on-Assets % -95.02%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 71.98
Book Value/Share 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar